Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pharmaceutical Cannabis Market Growth 2022-2028

  • LP 4823688
  • 94 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Pharmaceutical Cannabis will have significant change from previous year. According to our (LP Information) latest study, the global Pharmaceutical Cannabis market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pharmaceutical Cannabis market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Pharmaceutical Cannabis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pharmaceutical Cannabis market, reaching US$ million by the year 2028. As for the Europe Pharmaceutical Cannabis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Pharmaceutical Cannabis players cover Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc., and Aphria, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Cannabis market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

THC-dominant

CBD-dominant

Balanced THC & CBD

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Cancer

Arthritis

Migraine

Epilepsy

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Canopy Growth Corporation

GW Pharmaceuticals, plc

Aurora Cannabis, Inc.

Aphria, Inc.

MedReleaf Corporation

Insys Therapeutics, Inc.

CanniMed Therapeutics, Inc.

Cara Therapeutics, Inc.

United Cannabis Corporation

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pharmaceutical Cannabis Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pharmaceutical Cannabis by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pharmaceutical Cannabis by Country/Region, 2017, 2022 & 2028

2.2 Pharmaceutical Cannabis Segment by Type

2.2.1 THC-dominant

2.2.2 CBD-dominant

2.2.3 Balanced THC & CBD

2.3 Pharmaceutical Cannabis Sales by Type

2.3.1 Global Pharmaceutical Cannabis Sales Market Share by Type (2017-2022)

2.3.2 Global Pharmaceutical Cannabis Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pharmaceutical Cannabis Sale Price by Type (2017-2022)

2.4 Pharmaceutical Cannabis Segment by Application

2.4.1 Cancer

2.4.2 Arthritis

2.4.3 Migraine

2.4.4 Epilepsy

2.4.5 Others

2.5 Pharmaceutical Cannabis Sales by Application

2.5.1 Global Pharmaceutical Cannabis Sale Market Share by Application (2017-2022)

2.5.2 Global Pharmaceutical Cannabis Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pharmaceutical Cannabis Sale Price by Application (2017-2022)

3 Global Pharmaceutical Cannabis by Company

3.1 Global Pharmaceutical Cannabis Breakdown Data by Company

3.1.1 Global Pharmaceutical Cannabis Annual Sales by Company (2020-2022)

3.1.2 Global Pharmaceutical Cannabis Sales Market Share by Company (2020-2022)

3.2 Global Pharmaceutical Cannabis Annual Revenue by Company (2020-2022)

3.2.1 Global Pharmaceutical Cannabis Revenue by Company (2020-2022)

3.2.2 Global Pharmaceutical Cannabis Revenue Market Share by Company (2020-2022)

3.3 Global Pharmaceutical Cannabis Sale Price by Company

3.4 Key Manufacturers Pharmaceutical Cannabis Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pharmaceutical Cannabis Product Location Distribution

3.4.2 Players Pharmaceutical Cannabis Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pharmaceutical Cannabis by Geographic Region

4.1 World Historic Pharmaceutical Cannabis Market Size by Geographic Region (2017-2022)

4.1.1 Global Pharmaceutical Cannabis Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pharmaceutical Cannabis Annual Revenue by Geographic Region

4.2 World Historic Pharmaceutical Cannabis Market Size by Country/Region (2017-2022)

4.2.1 Global Pharmaceutical Cannabis Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pharmaceutical Cannabis Annual Revenue by Country/Region

4.3 Americas Pharmaceutical Cannabis Sales Growth

4.4 APAC Pharmaceutical Cannabis Sales Growth

4.5 Europe Pharmaceutical Cannabis Sales Growth

4.6 Middle East & Africa Pharmaceutical Cannabis Sales Growth

5 Americas

5.1 Americas Pharmaceutical Cannabis Sales by Country

5.1.1 Americas Pharmaceutical Cannabis Sales by Country (2017-2022)

5.1.2 Americas Pharmaceutical Cannabis Revenue by Country (2017-2022)

5.2 Americas Pharmaceutical Cannabis Sales by Type

5.3 Americas Pharmaceutical Cannabis Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pharmaceutical Cannabis Sales by Region

6.1.1 APAC Pharmaceutical Cannabis Sales by Region (2017-2022)

6.1.2 APAC Pharmaceutical Cannabis Revenue by Region (2017-2022)

6.2 APAC Pharmaceutical Cannabis Sales by Type

6.3 APAC Pharmaceutical Cannabis Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pharmaceutical Cannabis by Country

7.1.1 Europe Pharmaceutical Cannabis Sales by Country (2017-2022)

7.1.2 Europe Pharmaceutical Cannabis Revenue by Country (2017-2022)

7.2 Europe Pharmaceutical Cannabis Sales by Type

7.3 Europe Pharmaceutical Cannabis Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pharmaceutical Cannabis by Country

8.1.1 Middle East & Africa Pharmaceutical Cannabis Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pharmaceutical Cannabis Revenue by Country (2017-2022)

8.2 Middle East & Africa Pharmaceutical Cannabis Sales by Type

8.3 Middle East & Africa Pharmaceutical Cannabis Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Cannabis

10.3 Manufacturing Process Analysis of Pharmaceutical Cannabis

10.4 Industry Chain Structure of Pharmaceutical Cannabis

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pharmaceutical Cannabis Distributors

11.3 Pharmaceutical Cannabis Customer

12 World Forecast Review for Pharmaceutical Cannabis by Geographic Region

12.1 Global Pharmaceutical Cannabis Market Size Forecast by Region

12.1.1 Global Pharmaceutical Cannabis Forecast by Region (2023-2028)

12.1.2 Global Pharmaceutical Cannabis Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pharmaceutical Cannabis Forecast by Type

12.7 Global Pharmaceutical Cannabis Forecast by Application

13 Key Players Analysis

13.1 Canopy Growth Corporation

13.1.1 Canopy Growth Corporation Company Information

13.1.2 Canopy Growth Corporation Pharmaceutical Cannabis Product Offered

13.1.3 Canopy Growth Corporation Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Canopy Growth Corporation Main Business Overview

13.1.5 Canopy Growth Corporation Latest Developments

13.2 GW Pharmaceuticals, plc

13.2.1 GW Pharmaceuticals, plc Company Information

13.2.2 GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Offered

13.2.3 GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GW Pharmaceuticals, plc Main Business Overview

13.2.5 GW Pharmaceuticals, plc Latest Developments

13.3 Aurora Cannabis, Inc.

13.3.1 Aurora Cannabis, Inc. Company Information

13.3.2 Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Offered

13.3.3 Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Aurora Cannabis, Inc. Main Business Overview

13.3.5 Aurora Cannabis, Inc. Latest Developments

13.4 Aphria, Inc.

13.4.1 Aphria, Inc. Company Information

13.4.2 Aphria, Inc. Pharmaceutical Cannabis Product Offered

13.4.3 Aphria, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Aphria, Inc. Main Business Overview

13.4.5 Aphria, Inc. Latest Developments

13.5 MedReleaf Corporation

13.5.1 MedReleaf Corporation Company Information

13.5.2 MedReleaf Corporation Pharmaceutical Cannabis Product Offered

13.5.3 MedReleaf Corporation Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 MedReleaf Corporation Main Business Overview

13.5.5 MedReleaf Corporation Latest Developments

13.6 Insys Therapeutics, Inc.

13.6.1 Insys Therapeutics, Inc. Company Information

13.6.2 Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Offered

13.6.3 Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Insys Therapeutics, Inc. Main Business Overview

13.6.5 Insys Therapeutics, Inc. Latest Developments

13.7 CanniMed Therapeutics, Inc.

13.7.1 CanniMed Therapeutics, Inc. Company Information

13.7.2 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Offered

13.7.3 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 CanniMed Therapeutics, Inc. Main Business Overview

13.7.5 CanniMed Therapeutics, Inc. Latest Developments

13.8 Cara Therapeutics, Inc.

13.8.1 Cara Therapeutics, Inc. Company Information

13.8.2 Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Offered

13.8.3 Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Cara Therapeutics, Inc. Main Business Overview

13.8.5 Cara Therapeutics, Inc. Latest Developments

13.9 United Cannabis Corporation

13.9.1 United Cannabis Corporation Company Information

13.9.2 United Cannabis Corporation Pharmaceutical Cannabis Product Offered

13.9.3 United Cannabis Corporation Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 United Cannabis Corporation Main Business Overview

13.9.5 United Cannabis Corporation Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Pharmaceutical Cannabis Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pharmaceutical Cannabis Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of THC-dominant

Table 4. Major Players of CBD-dominant

Table 5. Major Players of Balanced THC & CBD

Table 6. Global Pharmaceutical Cannabis Sales by Type (2017-2022) & (K Units)

Table 7. Global Pharmaceutical Cannabis Sales Market Share by Type (2017-2022)

Table 8. Global Pharmaceutical Cannabis Revenue by Type (2017-2022) & ($ million)

Table 9. Global Pharmaceutical Cannabis Revenue Market Share by Type (2017-2022)

Table 10. Global Pharmaceutical Cannabis Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Pharmaceutical Cannabis Sales by Application (2017-2022) & (K Units)

Table 12. Global Pharmaceutical Cannabis Sales Market Share by Application (2017-2022)

Table 13. Global Pharmaceutical Cannabis Revenue by Application (2017-2022)

Table 14. Global Pharmaceutical Cannabis Revenue Market Share by Application (2017-2022)

Table 15. Global Pharmaceutical Cannabis Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Pharmaceutical Cannabis Sales by Company (2020-2022) & (K Units)

Table 17. Global Pharmaceutical Cannabis Sales Market Share by Company (2020-2022)

Table 18. Global Pharmaceutical Cannabis Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Pharmaceutical Cannabis Revenue Market Share by Company (2020-2022)

Table 20. Global Pharmaceutical Cannabis Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Pharmaceutical Cannabis Producing Area Distribution and Sales Area

Table 22. Players Pharmaceutical Cannabis Products Offered

Table 23. Pharmaceutical Cannabis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Pharmaceutical Cannabis Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Pharmaceutical Cannabis Sales Market Share Geographic Region (2017-2022)

Table 28. Global Pharmaceutical Cannabis Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Pharmaceutical Cannabis Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Pharmaceutical Cannabis Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Pharmaceutical Cannabis Sales Market Share by Country/Region (2017-2022)

Table 32. Global Pharmaceutical Cannabis Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Pharmaceutical Cannabis Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Pharmaceutical Cannabis Sales by Country (2017-2022) & (K Units)

Table 35. Americas Pharmaceutical Cannabis Sales Market Share by Country (2017-2022)

Table 36. Americas Pharmaceutical Cannabis Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Pharmaceutical Cannabis Revenue Market Share by Country (2017-2022)

Table 38. Americas Pharmaceutical Cannabis Sales by Type (2017-2022) & (K Units)

Table 39. Americas Pharmaceutical Cannabis Sales Market Share by Type (2017-2022)

Table 40. Americas Pharmaceutical Cannabis Sales by Application (2017-2022) & (K Units)

Table 41. Americas Pharmaceutical Cannabis Sales Market Share by Application (2017-2022)

Table 42. APAC Pharmaceutical Cannabis Sales by Region (2017-2022) & (K Units)

Table 43. APAC Pharmaceutical Cannabis Sales Market Share by Region (2017-2022)

Table 44. APAC Pharmaceutical Cannabis Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Pharmaceutical Cannabis Revenue Market Share by Region (2017-2022)

Table 46. APAC Pharmaceutical Cannabis Sales by Type (2017-2022) & (K Units)

Table 47. APAC Pharmaceutical Cannabis Sales Market Share by Type (2017-2022)

Table 48. APAC Pharmaceutical Cannabis Sales by Application (2017-2022) & (K Units)

Table 49. APAC Pharmaceutical Cannabis Sales Market Share by Application (2017-2022)

Table 50. Europe Pharmaceutical Cannabis Sales by Country (2017-2022) & (K Units)

Table 51. Europe Pharmaceutical Cannabis Sales Market Share by Country (2017-2022)

Table 52. Europe Pharmaceutical Cannabis Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Pharmaceutical Cannabis Revenue Market Share by Country (2017-2022)

Table 54. Europe Pharmaceutical Cannabis Sales by Type (2017-2022) & (K Units)

Table 55. Europe Pharmaceutical Cannabis Sales Market Share by Type (2017-2022)

Table 56. Europe Pharmaceutical Cannabis Sales by Application (2017-2022) & (K Units)

Table 57. Europe Pharmaceutical Cannabis Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Pharmaceutical Cannabis Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Pharmaceutical Cannabis Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Pharmaceutical Cannabis Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Pharmaceutical Cannabis Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Pharmaceutical Cannabis Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Pharmaceutical Cannabis

Table 67. Key Market Challenges & Risks of Pharmaceutical Cannabis

Table 68. Key Industry Trends of Pharmaceutical Cannabis

Table 69. Pharmaceutical Cannabis Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Pharmaceutical Cannabis Distributors List

Table 72. Pharmaceutical Cannabis Customer List

Table 73. Global Pharmaceutical Cannabis Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Pharmaceutical Cannabis Sales Market Forecast by Region

Table 75. Global Pharmaceutical Cannabis Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Pharmaceutical Cannabis Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Pharmaceutical Cannabis Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Pharmaceutical Cannabis Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Pharmaceutical Cannabis Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Pharmaceutical Cannabis Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Pharmaceutical Cannabis Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Pharmaceutical Cannabis Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Pharmaceutical Cannabis Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Pharmaceutical Cannabis Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Pharmaceutical Cannabis Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Pharmaceutical Cannabis Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Pharmaceutical Cannabis Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Pharmaceutical Cannabis Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Pharmaceutical Cannabis Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Application (2023-2028)

Table 93. Canopy Growth Corporation Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 94. Canopy Growth Corporation Pharmaceutical Cannabis Product Offered

Table 95. Canopy Growth Corporation Pharmaceutical Cannabis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Canopy Growth Corporation Main Business

Table 97. Canopy Growth Corporation Latest Developments

Table 98. GW Pharmaceuticals, plc Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 99. GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Offered

Table 100. GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. GW Pharmaceuticals, plc Main Business

Table 102. GW Pharmaceuticals, plc Latest Developments

Table 103. Aurora Cannabis, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 104. Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Offered

Table 105. Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Aurora Cannabis, Inc. Main Business

Table 107. Aurora Cannabis, Inc. Latest Developments

Table 108. Aphria, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 109. Aphria, Inc. Pharmaceutical Cannabis Product Offered

Table 110. Aphria, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Aphria, Inc. Main Business

Table 112. Aphria, Inc. Latest Developments

Table 113. MedReleaf Corporation Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 114. MedReleaf Corporation Pharmaceutical Cannabis Product Offered

Table 115. MedReleaf Corporation Pharmaceutical Cannabis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. MedReleaf Corporation Main Business

Table 117. MedReleaf Corporation Latest Developments

Table 118. Insys Therapeutics, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 119. Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Offered

Table 120. Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Insys Therapeutics, Inc. Main Business

Table 122. Insys Therapeutics, Inc. Latest Developments

Table 123. CanniMed Therapeutics, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 124. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Offered

Table 125. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. CanniMed Therapeutics, Inc. Main Business

Table 127. CanniMed Therapeutics, Inc. Latest Developments

Table 128. Cara Therapeutics, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 129. Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Offered

Table 130. Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Cara Therapeutics, Inc. Main Business

Table 132. Cara Therapeutics, Inc. Latest Developments

Table 133. United Cannabis Corporation Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors

Table 134. United Cannabis Corporation Pharmaceutical Cannabis Product Offered

Table 135. United Cannabis Corporation Pharmaceutical Cannabis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. United Cannabis Corporation Main Business

Table 137. United Cannabis Corporation Latest Developments

List of Figures

Figure 1. Picture of Pharmaceutical Cannabis

Figure 2. Pharmaceutical Cannabis Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pharmaceutical Cannabis Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Pharmaceutical Cannabis Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pharmaceutical Cannabis Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of THC-dominant

Figure 10. Product Picture of CBD-dominant

Figure 11. Product Picture of Balanced THC & CBD

Figure 12. Global Pharmaceutical Cannabis Sales Market Share by Type in 2021

Figure 13. Global Pharmaceutical Cannabis Revenue Market Share by Type (2017-2022)

Figure 14. Pharmaceutical Cannabis Consumed in Cancer

Figure 15. Global Pharmaceutical Cannabis Market: Cancer (2017-2022) & (K Units)

Figure 16. Pharmaceutical Cannabis Consumed in Arthritis

Figure 17. Global Pharmaceutical Cannabis Market: Arthritis (2017-2022) & (K Units)

Figure 18. Pharmaceutical Cannabis Consumed in Migraine

Figure 19. Global Pharmaceutical Cannabis Market: Migraine (2017-2022) & (K Units)

Figure 20. Pharmaceutical Cannabis Consumed in Epilepsy

Figure 21. Global Pharmaceutical Cannabis Market: Epilepsy (2017-2022) & (K Units)

Figure 22. Pharmaceutical Cannabis Consumed in Others

Figure 23. Global Pharmaceutical Cannabis Market: Others (2017-2022) & (K Units)

Figure 24. Global Pharmaceutical Cannabis Sales Market Share by Application (2017-2022)

Figure 25. Global Pharmaceutical Cannabis Revenue Market Share by Application in 2021

Figure 26. Pharmaceutical Cannabis Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Pharmaceutical Cannabis Revenue Market Share by Company in 2021

Figure 28. Global Pharmaceutical Cannabis Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Pharmaceutical Cannabis Revenue Market Share by Geographic Region in 2021

Figure 30. Global Pharmaceutical Cannabis Sales Market Share by Region (2017-2022)

Figure 31. Global Pharmaceutical Cannabis Revenue Market Share by Country/Region in 2021

Figure 32. Americas Pharmaceutical Cannabis Sales 2017-2022 (K Units)

Figure 33. Americas Pharmaceutical Cannabis Revenue 2017-2022 ($ Millions)

Figure 34. APAC Pharmaceutical Cannabis Sales 2017-2022 (K Units)

Figure 35. APAC Pharmaceutical Cannabis Revenue 2017-2022 ($ Millions)

Figure 36. Europe Pharmaceutical Cannabis Sales 2017-2022 (K Units)

Figure 37. Europe Pharmaceutical Cannabis Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Pharmaceutical Cannabis Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Pharmaceutical Cannabis Revenue 2017-2022 ($ Millions)

Figure 40. Americas Pharmaceutical Cannabis Sales Market Share by Country in 2021

Figure 41. Americas Pharmaceutical Cannabis Revenue Market Share by Country in 2021

Figure 42. United States Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Pharmaceutical Cannabis Sales Market Share by Region in 2021

Figure 47. APAC Pharmaceutical Cannabis Revenue Market Share by Regions in 2021

Figure 48. China Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Pharmaceutical Cannabis Sales Market Share by Country in 2021

Figure 55. Europe Pharmaceutical Cannabis Revenue Market Share by Country in 2021

Figure 56. Germany Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Pharmaceutical Cannabis Revenue Market Share by Country in 2021

Figure 63. Egypt Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Pharmaceutical Cannabis Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Pharmaceutical Cannabis in 2021

Figure 69. Manufacturing Process Analysis of Pharmaceutical Cannabis

Figure 70. Industry Chain Structure of Pharmaceutical Cannabis

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390